Invokana diabetes drug faces Canadian class-action lawsuit
Thursday, September 17, 2015 - 10:00
in Health & Medicine
The diabetes drug Invokana, recently adopted by Nova Scotia's pharmacare program, is now the subject of a national class-action lawsuit.